NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $80,829,554.26

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$120.17

▼ -1.04 (-0.86%)

As of 09/6/2024 01:00 AM ET

Days: 30 | 90 | 365

War on Elon Escalates…

From Porter & Company | Ad

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2024	William H. Rastetter	Director	Sell	14,250	$146.69	$2,090,332.50	37,491
8/13/2024	Gary A. Lyons	Director	Sell	11,570	$150.43	$1,740,475.10	119,047
8/13/2024	Ingrid Delaet	Insider	Sell	7,143	$150.10	$1,072,164.30	2,507
8/13/2024	Matt Abernethy	CFO	Sell	14,100	$150.38	$2,120,358.00	31,528
8/6/2024	Ingrid Delaet	Insider	Sell	273	$147.70	$40,322.10	6,607
8/1/2024	Julie Cooke	Insider	Sell	12,632	$153.26	$1,935,980.32	18,202
7/16/2024	Gary A. Lyons	Director	Sell	930	$150.03	$139,527.90	119,047
7/16/2024	Julie Cooke	Insider	Sell	900	$150.04	$135,036.00	18,202
7/1/2024	Julie Cooke	Insider	Sell	10,000	$140.19	$1,401,900.00	18,202
5/29/2024	Stephen A. Sherwin	Director	Sell	40,000	$133.46	$5,338,400.00	26,504
5/17/2024	Shalini Sharp	Director	Sell	1,106	$141.90	$156,941.40	994
5/15/2024	Matt Abernethy	CFO	Sell	15,000	$140.24	$2,103,600.00	31,528
5/14/2024	Gary A. Lyons	Director	Sell	12,500	$135.63	$1,695,375.00	116,947
5/6/2024	Ingrid Delaet	Insider	Sell	273	$140.55	$38,370.15	7,507
4/15/2024	Eric Benevich	Insider	Sell	19,818	$133.36	$2,642,928.48	40,778
3/21/2024	Ingrid Delaet	Insider	Sell	5,000	$145.06	$725,300.00	7,507
3/14/2024	Eric Benevich	Insider	Sell	75,000	$139.38	$10,453,500.00	40,778
3/14/2024	George J. Morrow	Director	Sell	40,000	$139.42	$5,576,800.00
3/11/2024	Ingrid Delaet	Insider	Sell	200	$140.00	$28,000.00	7,507
3/11/2024	Richard F. Pops	Director	Sell	100	$140.00	$14,000.00	29,512
3/8/2024	Ingrid Delaet	Insider	Sell	1,800	$140.03	$252,054.00	7,507
3/8/2024	Richard F. Pops	Director	Sell	1,700	$140.05	$238,085.00	29,512
2/29/2024	Ingrid Delaet	Insider	Sell	273	$135.51	$36,994.23	7,507
2/27/2024	Leslie V. Norwalk	Director	Sell	8,000	$135.67	$1,085,360.00
2/20/2024	Richard F. Pops	Director	Sell	15,000	$132.47	$1,987,050.00	29,512
2/13/2024	Eiry Roberts	Insider	Sell	1,114	$132.96	$148,117.44	23,716
2/13/2024	Kevin Charles Gorman	CEO	Sell	2,832	$133.02	$376,712.64	514,596
2/13/2024	Matt Abernethy	CFO	Sell	1,352	$132.85	$179,613.20	31,528
2/8/2024	David W. Boyer	Insider	Sell	1,328	$135.41	$179,824.48	4,895
2/8/2024	Kevin Charles Gorman	CEO	Sell	2,274	$134.15	$305,057.10	506,962
2/8/2024	Matt Abernethy	CFO	Sell	980	$134.21	$131,525.80	30,314
2/6/2024	David W. Boyer	Insider	Sell	456	$141.96	$64,733.76	4,894
2/6/2024	Kevin Charles Gorman	CEO	Sell	3,040	$142.18	$432,227.20	504,919
2/6/2024	Matt Abernethy	CFO	Sell	1,280	$142.19	$182,003.20	29,434
1/31/2024	Eiry Roberts	Insider	Sell	1,457	$140.79	$205,131.03	20,832
1/31/2024	Kevin Charles Gorman	CEO	Sell	2,707	$140.69	$380,847.83	502,188
1/31/2024	Matt Abernethy	CFO	Sell	1,283	$140.72	$180,543.76	28,284
1/22/2024	Darin Lippoldt	Insider	Sell	10,000	$139.86	$1,398,600.00	35,882
1/8/2024	Kevin Charles Gorman	CEO	Sell	105,835	$132.44	$14,016,787.40	499,754
1/2/2024	Kyle Gano	Insider	Sell	75,000	$131.47	$9,860,250.00	130,250
1/2/2024	William H. Rastetter	Director	Sell	11,044	$131.47	$1,451,954.68	51,741
12/22/2023	Eiry Roberts	Insider	Sell	10,000	$126.74	$1,267,400.00	19,521
12/12/2023	Eiry Roberts	Insider	Sell	13,925	$120.30	$1,675,177.50	29,521
12/8/2023	Eiry Roberts	Insider	Sell	300	$120.10	$36,030.00	29,521
12/6/2023	Darin Lippoldt	Insider	Sell	20,830	$119.86	$2,496,683.80	35,882
12/1/2023	Gary A. Lyons	Director	Sell	5,000	$116.77	$583,850.00	203,697
11/29/2023	Jude Onyia	Insider	Sell	2,331	$113.57	$264,731.67	11,732
11/27/2023	Darin Lippoldt	Insider	Sell	10,919	$112.27	$1,225,876.13	35,882
10/2/2023	David W. Boyer	Insider	Sell	1,437	$112.68	$161,921.16	4,894
9/12/2023	Gary A. Lyons	Director	Sell	5,000	$115.02	$575,100.00	203,697
9/1/2023	Gary A. Lyons	Director	Sell	5,000	$110.06	$550,300.00	203,697
9/1/2023	Julie Cooke	Insider	Sell	824	$110.93	$91,406.32	17,263
8/30/2023	David W. Boyer	Insider	Sell	2,733	$107.60	$294,070.80	3,460
8/28/2023	Ingrid Delaet	Insider	Sell	1,431	$107.52	$153,861.12	5,931
8/21/2023	Jude Onyia	Insider	Sell	3,198	$107.37	$343,369.26	9,638
8/21/2023	Kevin Charles Gorman	CEO	Sell	9,328	$107.40	$1,001,827.20	499,754
8/21/2023	Matt Abernethy	CFO	Sell	2,132	$107.39	$228,955.48	27,131
5/1/2023	Julie Cooke	Insider	Sell	11,397	$103.89	$1,184,034.33	16,169
5/1/2023	William H. Rastetter	Director	Sell	4,300	$101.43	$436,149.00	42,785
4/24/2023	Eiry Roberts	Insider	Sell	14,400	$103.48	$1,490,112.00	26,644
4/21/2023	William H. Rastetter	Director	Sell	6,034	$105.04	$633,811.36	39,460
4/19/2023	William H. Rastetter	Director	Sell	903	$105.00	$94,815.00	34,729
2/23/2023	Neurocrine Biosciences Inc	Major Shareholder	Buy	4,395,588	$8.88	$39,032,821.44	8,575,316
2/8/2023	Eric Benevich	Insider	Sell	980	$104.12	$102,037.60	34,381
2/8/2023	Kevin Charles Gorman	CEO	Sell	2,274	$104.30	$237,178.20	491,365
2/7/2023	Matt Abernethy	CFO	Sell	26,328	$102.40	$2,695,987.20	24,333
2/6/2023	Eric Benevich	Insider	Sell	1,280	$105.63	$135,206.40	17,879
2/6/2023	Kevin Charles Gorman	CEO	Sell	3,040	$105.68	$321,267.20	468,008
1/31/2023	Eiry Roberts	Insider	Sell	1,457	$109.99	$160,255.43	26,171
1/31/2023	Kevin Charles Gorman	CEO	Sell	2,707	$110.08	$297,986.56	465,278
1/31/2023	Matt Abernethy	CFO	Sell	1,283	$109.98	$141,104.34	21,357
1/6/2023	Eric Benevich	Insider	Sell	400	$125.00	$50,000.00	15,643
1/3/2023	Stephen A. Sherwin	Director	Sell	30,000	$118.86	$3,565,800.00	25,055
11/30/2022	Eric Benevich	Insider	Sell	50,000	$125.90	$6,295,000.00	15,643
11/10/2022	Eric Benevich	Insider	Sell	100	$125.36	$12,536.00	15,643
11/8/2022	Eric Benevich	Insider	Sell	24,593	$125.33	$3,082,240.69	15,643
11/3/2022	Darin Lippoldt	Insider	Sell	4,518	$125.02	$564,840.36	29,234
11/1/2022	Darin Lippoldt	Insider	Sell	10,000	$120.09	$1,200,900.00	29,234
10/31/2022	Gary A. Lyons	Director	Sell	15,000	$114.76	$1,721,400.00	203,697
10/27/2022	Darin Lippoldt	Insider	Sell	4,923	$115.04	$566,341.92	29,234
10/17/2022	Eric Benevich	Insider	Sell	4,960	$110.82	$549,667.20	15,643
10/4/2022	Gary A. Lyons	Director	Sell	5,000	$110.54	$552,700.00	203,697
10/3/2022	David W. Boyer	Insider	Sell	1,437	$106.59	$153,169.83	4,214
8/12/2022	Malcolm Lloyd-Smith	Insider	Sell	21,533	$105.95	$2,281,421.35	18,888
6/27/2022	Julie Cooke	Insider	Sell	754	$100.00	$75,400.00	16,918
5/9/2022	Richard F. Pops	Director	Sell	15,000	$76.30	$1,144,500.00	29,512
4/25/2022	Gary A. Lyons	Director	Sell	15,000	$92.76	$1,391,400.00	208,697
4/1/2022	William H. Rastetter	Director	Sell	10,728	$94.93	$1,018,409.04	34,022
3/22/2022	Darin Lippoldt	Insider	Sell	8,455	$95.05	$803,647.75
3/18/2022	Darin Lippoldt	Insider	Sell	300	$95.00	$28,500.00
2/7/2022	David W. Boyer	Insider	Sell	240	$81.07	$19,456.80
2/7/2022	Kevin Charles Gorman	CEO	Sell	8,710	$80.82	$703,942.20
2/7/2022	Matt Abernethy	CFO	Sell	3,310	$80.79	$267,414.90
1/24/2022	Stephen A. Sherwin	Director	Sell	15,000	$74.43	$1,116,450.00
1/10/2022	Eiry Roberts	Insider	Sell	2,632	$74.50	$196,084.00
1/5/2022	Kyle Gano	Insider	Sell	28,266	$85.50	$2,416,743.00
12/1/2021	Matt Abernethy	CFO	Sell	1,645	$82.59	$135,860.55
10/7/2021	Dimitri E. Grigoriadis	Insider	Sell	8,000	$104.81	$838,480.00
10/7/2021	Gary A. Lyons	Director	Sell	5,000	$105.06	$525,300.00
10/4/2021	Julie Cooke	Insider	Sell	987	$101.73	$100,407.51

Say Goodbye to the US Dollar

From Sasco Gold LLC | Ad

The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...

[RUSH MY FREE GUIDE]

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/5/2024	Sanctuary Advisors LLC	3,751	$0.51M	0.0%	N/A	0.004%
8/22/2024	Aurora Investment Counsel	10,437	$1.44M	0.8%	-1.1%	0.010%
8/22/2024	Cetera Investment Advisers	7,112	$0.98M	0.0%	+7.9%	0.007%
8/21/2024	Truist Financial Corp	31,546	$4.34M	0.0%	-15.5%	0.031%
8/16/2024	Perceptive Advisors LLC	649,909	$89.47M	2.1%	-19.2%	0.646%
8/16/2024	Northwestern Mutual Wealth Management Co.	757	$0.10M	0.0%	-92.9%	0.001%
8/16/2024	Driehaus Capital Management LLC	71,295	$9.82M	0.1%	-0.4%	0.071%
8/15/2024	Susquehanna Portfolio Strategies LLC	59,455	$8.19M	0.3%	-48.2%	0.059%
8/15/2024	Susquehanna Fundamental Investments LLC	3,695	$0.51M	0.0%	N/A	0.004%
8/15/2024	Scientech Research LLC	1,516	$0.21M	0.0%	-66.1%	0.002%
8/15/2024	Lion Point Capital LP	8,350	$1.15M	2.1%	+11.3%	0.008%
8/15/2024	Mackenzie Financial Corp	88,827	$12.23M	0.0%	-3.2%	0.088%
8/15/2024	The Manufacturers Life Insurance Company	125,401	$17.26M	0.0%	+0.9%	0.125%
8/15/2024	MBB Public Markets I LLC	7,132	$0.98M	0.0%	N/A	0.007%
8/15/2024	Daymark Wealth Partners LLC	1,774	$0.24M	0.0%	+18.3%	0.002%
8/15/2024	DSM Capital Partners LLC	997,784	$137.37M	2.0%	-12.2%	0.991%
8/15/2024	APG Asset Management N.V.	257,315	$33.05M	0.1%	-31.8%	0.256%
8/15/2024	APG Asset Management US Inc.	27,953	$3.92M	0.0%	+2.6%	0.028%
8/15/2024	AQR Capital Management LLC	1,223,055	$166.96M	0.3%	+23.0%	1.215%
8/15/2024	Armistice Capital LLC	978,488	$134.71M	1.7%	-4.4%	0.972%
8/15/2024	AXA S.A.	284,022	$39.10M	0.1%	+16.6%	0.282%
8/15/2024	Caxton Associates LP	18,121	$2.50M	0.1%	-2.2%	0.018%
8/15/2024	Toronto Dominion Bank	9,553	$1.32M	0.0%	-4.1%	0.009%
8/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	19,056	$2.62M	0.0%	+62.5%	0.019%
8/14/2024	Xponance Inc.	25,228	$3.47M	0.0%	-1.7%	0.025%
8/14/2024	Bank of Montreal Can	39,351	$5.42M	0.0%	-2.2%	0.039%
8/14/2024	Integral Health Asset Management LLC	70,000	$9.64M	0.9%	-53.3%	0.070%
8/14/2024	Hood River Capital Management LLC	243,897	$33.58M	0.7%	+7.0%	0.242%
8/14/2024	1832 Asset Management L.P.	541,200	$74.51M	0.1%	+1,370.7%	0.538%
8/14/2024	ProShare Advisors LLC	10,958	$1.51M	0.0%	-7.4%	0.011%
8/14/2024	Profund Advisors LLC	24,317	$3.35M	0.1%	+74.8%	0.024%
8/13/2024	Ensign Peak Advisors Inc	272,613	$37.53M	0.1%	+76.2%	0.271%
8/13/2024	Thrivent Financial for Lutherans	46,577	$6.41M	0.0%	+86.8%	0.046%
8/13/2024	Sei Investments Co.	128,016	$17.62M	0.0%	+47.7%	0.127%
8/13/2024	Pacer Advisors Inc.	31,890	$4.39M	0.0%	+76.1%	0.032%
8/13/2024	Skandinaviska Enskilda Banken AB publ	119,837	$16.50M	0.1%	+2.5%	0.119%
8/13/2024	Simplify Asset Management Inc.	22,834	$3.14M	0.2%	N/A	0.023%
8/13/2024	Canada Pension Plan Investment Board	66,449	$9.15M	0.0%	-64.8%	0.066%
8/13/2024	Public Employees Retirement Association of Colorado	11,113	$1.53M	0.0%	-3.9%	0.011%
8/12/2024	Intech Investment Management LLC	68,698	$9.46M	0.1%	+184.0%	0.068%
8/12/2024	Inspire Investing LLC	4,523	$0.62M	0.1%	-63.2%	0.004%
8/12/2024	MQS Management LLC	2,872	$0.40M	0.2%	-28.2%	0.003%
8/12/2024	XTX Topco Ltd	3,343	$0.46M	0.0%	-57.2%	0.003%
8/12/2024	Seven Eight Capital LP	7,862	$1.08M	0.1%	+370.2%	0.008%
8/12/2024	Hsbc Holdings PLC	113,073	$15.58M	0.0%	-19.2%	0.112%
8/12/2024	Blair William & Co. IL	7,827	$1.08M	0.0%	-9.0%	0.008%
8/12/2024	Vanguard Personalized Indexing Management LLC	9,064	$1.24M	0.0%	+3.7%	0.009%
8/12/2024	Amalgamated Bank	52,071	$7.17M	0.1%	-5.6%	0.052%
8/12/2024	Tredje AP fonden	18,728	$2.58M	0.0%	-1.5%	0.019%
8/12/2024	Meiji Yasuda Asset Management Co Ltd.	7,284	$1M	0.0%	+15.5%	0.007%
8/12/2024	Mercer Global Advisors Inc. ADV	8,123	$1.12M	0.0%	+5.6%	0.008%
8/12/2024	Meiji Yasuda Life Insurance Co	5,800	$0.80M	0.0%	+75.8%	0.006%
8/12/2024	E Fund Management Co. Ltd.	7,319	$1.01M	0.1%	+135.1%	0.007%
8/10/2024	Mutual of America Capital Management LLC	57,621	$7.93M	0.1%	-2.8%	0.057%
8/9/2024	Edgestream Partners L.P.	44,194	$6.08M	0.3%	+84.1%	0.044%
8/9/2024	Primecap Management Co. CA	409,290	$56.35M	0.0%	+2.5%	0.407%
8/9/2024	Renaissance Technologies LLC	2,468,146	$339.79M	0.6%	+9.6%	2.453%
8/9/2024	Total Clarity Wealth Management Inc.	2,433	$0.34M	0.1%	+4.3%	0.002%
8/9/2024	Dimensional Fund Advisors LP	472,929	$65.10M	0.0%	+45.5%	0.470%
8/9/2024	Massachusetts Financial Services Co. MA	155,985	$21.47M	0.0%	+2.7%	0.155%
8/9/2024	Plato Investment Management Ltd	425	$59K	0.0%	+44.1%	0.000%
8/9/2024	WINTON GROUP Ltd	10,689	$1.47M	0.1%	N/A	0.011%
8/8/2024	Envestnet Asset Management Inc.	202,793	$27.92M	0.0%	+1.7%	0.202%
8/8/2024	Oppenheimer Asset Management Inc.	15,146	$2.09M	0.0%	+12.9%	0.015%
8/8/2024	Dai ichi Life Insurance Company Ltd	48,477	$6.67M	0.2%	+131.4%	0.048%
8/8/2024	Federated Hermes Inc.	111,055	$15.29M	0.0%	+3.6%	0.110%
8/8/2024	DekaBank Deutsche Girozentrale	113,586	$15.21M	0.0%	-2.3%	0.113%
8/8/2024	Oppenheimer & Co. Inc.	17,238	$2.37M	0.0%	+1.7%	0.017%
8/8/2024	Nicholas Investment Partners LP	2,931	$0.40M	0.0%	N/A	0.003%
8/8/2024	Cornercap Investment Counsel Inc.	8,894	$1.22M	0.2%	N/A	0.009%
8/8/2024	Achmea Investment Management B.V.	3,143	$0.43M	0.0%	+31.6%	0.003%
8/8/2024	Forsta AP Fonden	32,600	$4.49M	0.0%	-4.7%	0.032%
8/8/2024	Jupiter Asset Management Ltd.	307,100	$42.28M	0.4%	+40.6%	0.305%
8/8/2024	American Century Companies Inc.	198,536	$27.33M	0.0%	-48.3%	0.197%
8/8/2024	State of New Jersey Common Pension Fund D	38,196	$5.26M	0.0%	-32.4%	0.038%
8/8/2024	Rice Hall James & Associates LLC	118,105	$16.26M	1.0%	-6.6%	0.117%
8/7/2024	Headlands Technologies LLC	9,063	$1.25M	0.1%	+4,477.3%	0.009%
8/7/2024	Daiwa Securities Group Inc.	8,801	$1.21M	0.0%	+2.5%	0.009%
8/7/2024	Andra AP fonden	161,300	$22.21M	0.4%	+116.8%	0.160%
8/7/2024	Texas Permanent School Fund Corp	80,235	$11.05M	0.1%	-7.9%	0.080%
8/7/2024	Choreo LLC	1,741	$0.24M	0.0%	N/A	0.002%
8/7/2024	Prudential PLC	15,533	$2.14M	0.0%	-15.7%	0.015%
8/7/2024	Ashton Thomas Private Wealth LLC	204	$28K	0.0%	N/A	0.000%
8/6/2024	Quest Partners LLC	451	$62K	0.0%	-89.1%	0.000%
8/6/2024	Pier 88 Investment Partners LLC	3,550	$0.49M	0.1%	+144.8%	0.004%
8/6/2024	Caprock Group LLC	1,669	$0.23M	0.0%	+7.0%	0.002%
8/6/2024	Acadian Asset Management LLC	4,164	$0.57M	0.0%	+20.1%	0.004%
8/6/2024	Great Lakes Advisors LLC	111,278	$15.32M	0.1%	-3.8%	0.111%
8/6/2024	Los Angeles Capital Management LLC	56,885	$7.83M	0.0%	-76.8%	0.057%
8/6/2024	Savant Capital LLC	7,163	$0.99M	0.0%	-54.1%	0.007%
8/6/2024	Candriam S.C.A.	465,467	$64.08M	0.4%	+47.4%	0.463%
8/5/2024	Arizona State Retirement System	27,334	$3.76M	0.0%	+1.1%	0.027%
8/5/2024	Victory Capital Management Inc.	137,543	$18.94M	0.0%	+1.2%	0.137%
8/3/2024	Impact Partnership Wealth LLC	2,061	$0.28M	0.1%	N/A	0.002%
8/3/2024	TD Asset Management Inc	140,267	$19.31M	0.0%	-2.2%	0.139%
8/2/2024	Belpointe Asset Management LLC	8,113	$1.12M	0.1%	+91.5%	0.008%
8/2/2024	Larson Financial Group LLC	1,893	$0.26M	0.0%	-14.5%	0.002%
8/2/2024	Fortis Capital Advisors LLC	8,113	$1.12M	0.4%	+91.5%	0.008%
8/2/2024	Oregon Public Employees Retirement Fund	20,952	$2.88M	0.1%	-14.8%	0.021%
8/1/2024	Fiera Capital Corp	527,902	$72.68M	0.2%	+3.2%	0.525%

Data available starting January 2016

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Today's Range

Now: $120.17

$119.85

$122.75

50 Day Range

MA: $142.72

$120.17

$153.15

52 Week Range

Now: $120.17

$103.63

$157.98

Volume

868,975 shs

Average Volume

854,996 shs

Market Capitalization

$12.09 billion

P/E Ratio

33.10

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Kyle Gano (Insider)
William H Rastetter (Director)
Eric Benevich (Insider)
Darin Lippoldt (Insider)
Matt Abernethy (CFO)
Eiry Roberts (Insider)
Richard F Pops (Director)
Stephen A Sherwin (Director)
Julie Cooke (Insider)
Jude Onyia (Insider)
Ingrid Delaet (Insider)
David W Boyer (Insider)
Shalini Sharp (Director)
George J Morrow (Director)
Leslie V Norwalk (Director)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
Renaissance Technologies LLC — 2.45%
AQR Capital Management LLC — 1.22%
DSM Capital Partners LLC — 0.99%
Armistice Capital LLC — 0.97%
Bank of New York Mellon Corp — 0.93%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 0.78%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Panagora Asset Management Inc.
Los Angeles Capital Management LLC
American Century Companies Inc.
Perceptive Advisors LLC
DSM Capital Partners LLC
Canada Pension Plan Investment Board
APG Asset Management N.V.
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Kyle Gano (Insider)
William H Rastetter (Director)
Eric Benevich (Insider)
Darin Lippoldt (Insider)
Matt Abernethy (CFO)
Eiry Roberts (Insider)
Richard F Pops (Director)
Stephen A Sherwin (Director)
Julie Cooke (Insider)
Jude Onyia (Insider)
Ingrid Delaet (Insider)
David W Boyer (Insider)
Shalini Sharp (Director)
George J Morrow (Director)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
1832 Asset Management L.P.
AQR Capital Management LLC
Renaissance Technologies LLC
Allspring Global Investments Holdings LLC
Candriam S.C.A.
Dimensional Fund Advisors LP
Ensign Peak Advisors Inc
Jupiter Asset Management Ltd.